Results 11 to 20 of about 9,152,470 (385)

An Empirical Biomarker-based Calculator for Autosomal Recessive Polycystic Kidney Disease - The Nieto-Narayan Formula [PDF]

open access: yes, 2016
Autosomal polycystic kidney disease (ARPKD) is associated with progressive enlargement of the kidneys fuelled by the formation and expansion of fluid-filled cysts.
Goldberg, Itzhak D.   +3 more
core   +16 more sources

Nutritional Management in Polycystic Ovary Syndrome: Challenges and opportunities [PDF]

open access: yes, 2021
PCOS is one of the most common endocrine diseases affecting women of reproductive age. Its etiology remains unresolved but it is thought to have a genetic basis as well as interactions with other environmental factors.
Ghazeeri, G.   +5 more
core   +1 more source

Polycystic liver disease: Classification, diagnosis, treatment process, and clinical management

open access: yesWorld Journal of Hepatology, 2020
Polycystic liver disease (PLD) is a rare hereditary disease that independently exists in isolated PLD, or as an accompanying symptom of autosomal dominant polycystic kidney disease and autosomal recessive polycystic kidney disease with complicated ...
Zeyu Zhang, Zhiming Wang, Yun Huang
semanticscholar   +1 more source

The essentials for stress-free management of patients with polycystic kidney disease on peritoneal dialysis.

open access: yesBulletin de la Dialyse à Domicile, 2023
Summary Autosomal dominant polycystic hepatorenal disease is a common chronic kidney disease. Among the proposed replacement therapies, peritoneal dialysis (PD) concerns less than 7% of polycystic patients. The underutilization of PD is due to the fear
Fatouma Toure
doaj   +1 more source

Causal relationship between polycystic ovary syndrome and chronic kidney disease: A Mendelian randomization study

open access: yesFrontiers in Endocrinology, 2023
ObjectivePolycystic ovary syndrome is one of the most common endocrine disorders among women of childbearing age. The relationship between polycystic ovary syndrome and chronic kidney disease remains unclear and controversial.
Yufei Du   +4 more
doaj   +1 more source

Health disparities in chronic liver disease

open access: yesHepatology, EarlyView., 2022
Abstract The syndemic of hazardous alcohol consumption, opioid use, and obesity has led to important changes in liver disease epidemiology that have exacerbated health disparities. Health disparities occur when plausibly avoidable health differences are experienced by socially disadvantaged populations.
Ani Kardashian   +3 more
wiley   +1 more source

Impaired carotid viscoelastic properties in women with polycystic ovaries [PDF]

open access: yes, 2002
Background-The purpose of this study was to assess the elastic properties of the carotid arteries in women with polycystic ovarian syndrome, asymptomatic women with polycystic ovaries.
Hardiman, P, Lakhani, K, Seifalian, AM
core   +1 more source

Atypical Polycystic Kidney Disease as defined by Imaging

open access: yesScientific Reports, 2023
Using age- and height-adjusted total kidney volume, the Mayo Clinic Imaging Classification provides a validated approach to assess the risk of chronic kidney disease (CKD) progression in autosomal dominant polycystic kidney disease (ADPKD), but requires ...
Ioan-Andrei Iliuta   +13 more
doaj   +1 more source

Vasopressin regulates the growth of the biliary epithelium in polycystic liver disease [PDF]

open access: yes, 2016
The neurohypophysial hormone arginine vasopressin (AVP) acts by three distinct receptor subtypes: V1a, V1b, and V2. In the liver, AVP is involved in ureogenesis, glycogenolysis, neoglucogenesis and regeneration. No data exist about the presence of AVP in
Alpini, Gianfranco   +11 more
core   +1 more source

Magnetic resonance imaging 3t and total fibrotic volume in autosomal dominant polycystic kidney disease [PDF]

open access: yes, 2018
INTRODUCTION: Autosomal dominant polycystic kidney disease (ADPKD) is the most common renal hereditary disorder. Several authors have attempted to identify a kidney damage marker for predicting the prognosis and the effectiveness of therapy in ADPKD ...
Ciccariello, Mauro   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy